Fox Chase Cancer Center Endowed Chairs

Joe is unique. He has a vast understanding of both cytogenetics and molecular biology and was trained by some of the best scientific minds of our time. His talents have been a marvelous fit with Fox Chase. When we hired Joe, I thought to myself, 'This is perfect!' And it was."
— Alfred G. Knudson Jr., MD, PhD
Senior Advisor to the President,
Fox Chase Distinguished Scientist
Launch the video: Endowed Chairs, a Living, Life-Giving Legacy

Hear from researchers why endowing a chair is so important to Fox Chase Cancer Center research, and to our patients.
See the video (7 min 25 sec)

Fox Chase Cancer Center Endowed Chair Program logoCarol and Kenneth Weg Chair in Human Genetics

Fox Chase Cancer Center Board Member Kenneth E. Weg and wife Carol Weg established this chair in 1998 to recognize and support an outstanding leader in the fields of cancer research and human genetics who represents the highest standards of excellence.

Joseph R. Testa, PhD

Joseph R. Testa, PhD

Co-Director,
Cancer Signaling and Genetics Program
Co-Leader,
Keystone Program in Personalized Kidney Care

Dr. Joseph Testa’s work focuses on genetic alterations in mesothelioma, a cancer linked to asbestos exposure, and AKT oncogenic activity. He has identified frequent mutations of the tumor suppressor genes NF2 and CDKN2A/ARF in mesothelioma, and reported a mouse model that recapitulates molecular features of the human disease. His group is unraveling the role of NF2 inactivation in oncogenic cell signaling.

The Testa lab first characterized the AKT2 gene and showed it to be over-expressed in ovarian and pancreatic cancers. His group also found that knockdown of AKT2 inhibits the malignant phenotype of tumor cells over-expressing this gene, thus implicating AKT signaling as a potential target for therapeutic intervention. He has also documented frequent activation of AKT in many kinds of cancer and shown that inhibiting AKT can sensitize tumor cells to therapy-induced apoptosis.

Dr. Testa has received several awards, including the Stohlman Memorial Scholar Award from the Leukemia Society of America and the Selikoff Award for Cancer Research from the Ramazzini Institute. He is a member of the NCI Board of Scientific Counselors and is an editorial board member of six journals. He was named the inaugural Carol & Kenneth Weg Chair in Human Genetics in 1999.

For information about how to support Fox Chase's endowed funds, please contact:


Rich Santoro
Senior Director, Major and Planned Gifts
Institutional Advancement
Fox Chase Cancer Center
333 Cottman Avenue
Philadelphia, PA 19111
Tel: 215-728-3192
Fax: 215-728-2759
rich.santoro@fccc.edu